[go: up one dir, main page]

AR014881A1 - USE OF AN INSULIN SENSITIZER AND AN ANTIHIPERGLUCEMIC AGENT FOR THE PREPARATION OF A PHARMACEUTICAL MEDICINAL AND COMPOSITION THAT UNDERSTANDS SENSITIZER AND SUCH AGENT - Google Patents

USE OF AN INSULIN SENSITIZER AND AN ANTIHIPERGLUCEMIC AGENT FOR THE PREPARATION OF A PHARMACEUTICAL MEDICINAL AND COMPOSITION THAT UNDERSTANDS SENSITIZER AND SUCH AGENT

Info

Publication number
AR014881A1
AR014881A1 ARP980102885A ARP980102885A AR014881A1 AR 014881 A1 AR014881 A1 AR 014881A1 AR P980102885 A ARP980102885 A AR P980102885A AR P980102885 A ARP980102885 A AR P980102885A AR 014881 A1 AR014881 A1 AR 014881A1
Authority
AR
Argentina
Prior art keywords
agent
sensitizer
preparation
antihiperglucemic
understands
Prior art date
Application number
ARP980102885A
Other languages
Spanish (es)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712865.6A external-priority patent/GB9712865D0/en
Priority claimed from GBGB9806708.5A external-priority patent/GB9806708D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR014881A1 publication Critical patent/AR014881A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Uso de un sensibilizador a insulina y un agente antihiperglucémico para la preparacion de un medicamento util para el tratamiento de la diabetes mellitusy condiciones asociadas con la diabetes mellitus en un mamífero, que comprende una cantidad eficaz no toxica y farmacéuticamente aceptable de unsensibilizador a insulina y de un agente antihiperglucémico inhibidor de alfa-glucosidasa, a un mamífero que necesita de ello; y composicionfarmacéutica que comprende dicho sensibilizador y dichoagente.Use of an insulin sensitizer and an antihyperglycemic agent for the preparation of a medicament useful for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, comprising an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitizer and an anti-hyperglycemic alpha-glucosidase inhibitor agent, to a mammal that needs it; and pharmaceutical composition comprising said sensitizer and said agent.

ARP980102885A 1997-06-18 1998-06-17 USE OF AN INSULIN SENSITIZER AND AN ANTIHIPERGLUCEMIC AGENT FOR THE PREPARATION OF A PHARMACEUTICAL MEDICINAL AND COMPOSITION THAT UNDERSTANDS SENSITIZER AND SUCH AGENT AR014881A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9712865.6A GB9712865D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
GBGB9806708.5A GB9806708D0 (en) 1998-03-27 1998-03-27 Novel method

Publications (1)

Publication Number Publication Date
AR014881A1 true AR014881A1 (en) 2001-04-11

Family

ID=26311746

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP980102885A AR014881A1 (en) 1997-06-18 1998-06-17 USE OF AN INSULIN SENSITIZER AND AN ANTIHIPERGLUCEMIC AGENT FOR THE PREPARATION OF A PHARMACEUTICAL MEDICINAL AND COMPOSITION THAT UNDERSTANDS SENSITIZER AND SUCH AGENT
ARP980102882A AR013352A1 (en) 1997-06-18 1998-06-17 USE OF AN INSULIN SENSITIZER AND AN ANTI-HYPERGLYCEMIC AGENT FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF DIABETES MELLITUS AND CONDITIONS ASSOCIATED WITH IT AND A PHARMACEUTICAL COMPOSITION.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP980102882A AR013352A1 (en) 1997-06-18 1998-06-17 USE OF AN INSULIN SENSITIZER AND AN ANTI-HYPERGLYCEMIC AGENT FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF DIABETES MELLITUS AND CONDITIONS ASSOCIATED WITH IT AND A PHARMACEUTICAL COMPOSITION.

Country Status (24)

Country Link
EP (1) EP0975343A1 (en)
JP (1) JP2001523271A (en)
KR (1) KR20010013845A (en)
CN (1) CN1274282A (en)
AP (1) AP9901720A0 (en)
AR (2) AR014881A1 (en)
AU (1) AU8799998A (en)
BG (1) BG103966A (en)
BR (1) BR9810186A (en)
CA (1) CA2294134A1 (en)
CO (1) CO4940453A1 (en)
DZ (1) DZ2519A1 (en)
EA (1) EA200000040A1 (en)
IL (1) IL133138A0 (en)
MA (1) MA26510A1 (en)
NO (1) NO996270D0 (en)
NZ (1) NZ501345A (en)
OA (1) OA11631A (en)
PE (1) PE89199A1 (en)
PL (1) PL337577A1 (en)
SK (1) SK179499A3 (en)
TR (1) TR199903072T2 (en)
UY (1) UY25051A1 (en)
WO (1) WO1998057635A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
CA2370258A1 (en) 1999-04-23 2000-11-02 Paul David James Blackler Thiazolidinedione derivative and its use as antidiabetic
ES2321815T3 (en) 2001-04-04 2009-06-12 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. THERAPEUTIC COMBINATION THAT INCLUDES REABSORTION AND GLUCOSE INHIBITORS AND PPAR MODULATORS.
ATE442148T1 (en) 2001-04-04 2009-09-15 Ortho Mcneil Janssen Pharm COMBINATION THERAPY USING GLUCOSE ABSORPTION INHIBITORS AND RETINOID X RECEPTOR MODULATORS
FR2832930A1 (en) * 2001-12-03 2003-06-06 Lipha PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES
JP2004067575A (en) * 2002-08-06 2004-03-04 Yaizu Suisankagaku Industry Co Ltd Promoter for effect of therapeutic agent for diabetes
CN101121004B (en) * 2006-08-08 2010-07-21 鲁南制药集团股份有限公司 Medicine composition containing insulin intensifier and miglitol
CN101584705B (en) * 2008-05-24 2010-10-27 鲁南制药集团股份有限公司 A kind of pharmaceutical composition for treating diabetes and its complications
CN101584688B (en) * 2008-05-24 2010-11-10 鲁南制药集团股份有限公司 Medicament composition for treating diabetes and complications of diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003724A1 (en) * 1991-08-26 1993-03-04 The Upjohn Company Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
EA200000040A1 (en) 2000-08-28
KR20010013845A (en) 2001-02-26
UY25051A1 (en) 2000-09-29
EP0975343A1 (en) 2000-02-02
DZ2519A1 (en) 2003-02-01
NO996270L (en) 1999-12-17
AP9901720A0 (en) 1999-12-31
PE89199A1 (en) 1999-10-23
PL337577A1 (en) 2000-08-28
AR013352A1 (en) 2000-12-27
CA2294134A1 (en) 1998-12-23
AU8799998A (en) 1999-01-04
SK179499A3 (en) 2000-11-07
WO1998057635A1 (en) 1998-12-23
IL133138A0 (en) 2001-03-19
JP2001523271A (en) 2001-11-20
TR199903072T2 (en) 2000-07-21
CN1274282A (en) 2000-11-22
CO4940453A1 (en) 2000-07-24
BR9810186A (en) 2000-08-08
BG103966A (en) 2000-07-31
OA11631A (en) 2004-11-22
NO996270D0 (en) 1999-12-17
MA26510A1 (en) 2004-12-20
NZ501345A (en) 2001-10-26

Similar Documents

Publication Publication Date Title
AR012998A1 (en) USE OF AN INSULIN SENSITIZER AND AN ANTI-HYPERGLYCEMIC AGENT FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH SENSITIZER AND SUCH AGENT.
UY25799A1 (en) PHARMACEUTICAL COMPOSITION OF MODIFIED RELEASE INCLUDING AN INSULIN SENSITIZER AND ANOTHER ANTI-DIABETIC AGENT.
CL2009001899A1 (en) Pharmaceutical composition comprising: i) an at1 receptor antagonist or a salt, ii) an insulin sensitizer or a salt and iii) a pharmaceutically acceptable carrier; use for the prevention, delay of progress or treatment of hypertension, diabetes, among others (div. sol. 2034-01).
AR033688A1 (en) RECONSTITUABLE PARENTERAL COMPOSITION
AR005281A1 (en) ORAL PHARACEUTICAL COMPOSITION, PROCEDURES FOR ITS MANUFACTURE AND USE OF THAT PHARMACEUTICAL COMPOSITION FOR THE PREPARATION OF MEDICINES. .
BRPI0410260A (en) drug conjugate composition
ES2156840T1 (en) MEDICINAL PRODUCT CONTAINING PENTOSANE POLYSULFATE AND IMPLANT TO TREAT FIBROSIS.
CL2008003938A1 (en) Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00).
BR9810445A (en) Diabetes treatment with thiazolidinedione, insulin secretagogue and diguanide
AR014881A1 (en) USE OF AN INSULIN SENSITIZER AND AN ANTIHIPERGLUCEMIC AGENT FOR THE PREPARATION OF A PHARMACEUTICAL MEDICINAL AND COMPOSITION THAT UNDERSTANDS SENSITIZER AND SUCH AGENT
UY25798A1 (en) PHARMACEUTICAL COMPOSITION OF MODIFIED RELEASE INCLUDING A THIAZOLIDINADIONIC INSULIN SENSITIZER.
AR015894A1 (en) USE OF 5- [4- [2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] BENCIL] TIAZOLIDIN-2,4-DIONA AND INSULIN FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINS SUCH COMPOUNDS
AR016350A1 (en) USE OF AN INSULIN SENSITIZER, AN INSULIN SECRETAGOG AND AN ALFA-GLUCOSIDASE INHIBITING ANTI-HERITAGE AGENT TO PREPARE MEDICATIONS
AR012996A1 (en) USE OF AN INSULIN SENSITIZER FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH SENSITIZER.
AR011437A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MIGRANES AND THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT.
UY25103A1 (en) COMPOSITION FOR THE TREATMENT OF DIABETES MELLITUS
AR012638A1 (en) USE OF PREGNAN-3-OL-20-ONAS FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT TO PROVIDE PROGESTATIONAL THERAPY
ES2033181B1 (en) A TABLET OR CAPSULE OF HERBICIDE FOR APPLICATION IN RICE.
AR007058A1 (en) USE OF INTERFERON IN MEDICINES AND COMPOSITIONS FOR OROMUCOSAL CONTACT
ECSP982541A (en) NEW METHOD OF TREATMENT II
ECSP982535A (en) NEW TREATMENT METHOD (I)
ECSP993215A (en) NEW COMPOSITION AND USE
ECSP982591A (en) NEW METHOD OF TREATMENT IV
ECSP982593A (en) NEW METHOD OF TREATMENT VI
ECSP982592A (en) NEW METHOD OF TREATMENT V

Legal Events

Date Code Title Description
FB Suspension of granting procedure